Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. (APRE) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 164 transactions totaling $93.5M, demonstrating a bearish sentiment with -$34.2M in net insider flow. The most recent transaction on Dec 10, 2025 involved a purchase of 5,000 shares valued at $5.8K.
APRE Insider Activity Summary
Who Is Buying APRE Stock?
No significant insider buying has been recorded for APRE in the recent period.
Who Is Selling APRE Stock?
No significant insider selling has been recorded for APRE in the recent period.
Is Aprea Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for APRE is bearish with an Insider Alignment Score of 32/100 and a net flow of -$34.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
APRE Frequently Asked Questions
Understanding APRE Insider Activity
Insider trading at Aprea Therapeutics, Inc. (APRE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading APRE stock, having executed 164 transactions in the past 90 days. The most active insider is Scott M. Rocklage (Executive), who has made 10 transactions totaling $20.0M.
Related Tools
Track Aprea Therapeutics, Inc. Insider Activity
Get notified when executives and directors at APRE file new Form 4 transactions